|
KMID : 0352720190430010058
|
|
Journal of Ginseng Research
2019 Volume.43 No. 1 p.58 ~ p.67
|
|
|
GS-KG9 ameliorates diabetic neuropathic pain induced by streptozotocin in rats
|
|
Lee Jee-Youn
Choi Hae-Young
Park Chan-Sol
Pyo Mi-Kyung
Yune Tae-Young
Kim Go-Woon
Chung Sung-Hyun
|
|
|
Abstract
|
|
|
Background: Diabetic neuropathy is one of the most devastating ailments of the peripheral nervous system. Neuropathic pain develops in ∼30% of diabetics. Here, we examined the suppressive effect of GS-KG9 on neuropathic pain induced by streptozotocin (STZ).
Methods: Hyperglycemia was induced by intraperitoneal injection of STZ. Rats showing blood glucose level > 250 mg/dL were divided into five groups, and treatment groups received oral saline containing GS-KG9 (50 mg/kg, 150 mg/kg, or 300 mg/kg) twice daily for 4 wk. The effects of GS-KG9 on pain behavior, microglia activation in the lumbar spinal cord and ventral posterolateral (VPL) nucleus of the thalamus, and c-Fos expression in the dorsal horn of the lumbar spinal cord were examined.
Results: The development of neuropathic pain began at Day 5 and peaked at Week 4 after STZ injection. Mechanical and thermal pains were both significantly attenuated in GS-KG9-treated groups from 10 d after STZ injection as compared to those in the STZ control. GS-KG9 also repressed microglia activation in L4 dorsal horn and VPL region of the thalamus. In addition, increase in c-Fos-positive cells within L4 dorsal horn lamina I and II of the STZ control group was markedly alleviated by GS-KG9.
Conclusion: These results suggest that GS-KG9 effectively relieves STZ-induced neuropathic pain by inhibiting microglial activation in the spinal cord dorsal horn and VPL region of the thalamus.
|
|
|
KEYWORD
|
|
|
dorsal horn, microglia, neuropathic pain, streptozotocin, ventral posterolateral nucleus
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|